sch 45752 has been researched along with benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone in 1 studies
| Studies (sch 45752) | Trials (sch 45752) | Recent Studies (post-2010) (sch 45752) | Studies (benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone) | Trials (benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone) | Recent Studies (post-2010) (benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone) |
|---|---|---|---|---|---|
| 13 | 0 | 3 | 1,897 | 0 | 411 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, WL; Chiang, CP; Chung, CL; Guh, JH; Hsiao, CJ; Hsiao, G; Lee, TH; Liu, LY; Wang, SW | 1 |
1 other study(ies) available for sch 45752 and benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone
| Article | Year |
|---|---|
Cephalochromin induces G0/G1 cell cycle arrest and apoptosis in A549 human non-small-cell lung cancer cells by inflicting mitochondrial disruption.
Topics: Amino Acid Chloromethyl Ketones; Apoptosis; Carcinoma, Non-Small-Cell Lung; Caspase 3; Caspase Inhibitors; Caspases; Cell Cycle; Cephalosporins; Dose-Response Relationship, Drug; Down-Regulation; G1 Phase; G1 Phase Cell Cycle Checkpoints; Humans; Inhibitory Concentration 50; Lung Neoplasms; Membrane Potential, Mitochondrial; Mitochondria; Molecular Structure; Poly(ADP-ribose) Polymerases | 2014 |